Executive Summary
The case involves Novartis AG seeking a permanent injunction against MSN Laboratories Pvt. Ltd. for infringing its patent related to Eltrombopag Olamine, the active ingredient in its drug Revolade.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Delhi High Court - Orders. Understanding the court's reasoning in Novartis Ag vs Msn Laboratories Pvt. Ltd is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Kent Ro Systems Ltd And AnrvsDilip Kumar Shukla & Ors.
In this ongoing commercial suit concerning alleged infringement and passing off related to Kent RO's products, the court addressed a procedural challenge regarding one of the defendants. The defendant argued that the design right relevant to their involvement had expired, prompting the plaintiff to consider removing them from the case. While no final judgment was reached, the court issued several directions for the completion of pleadings and document exchange.
M/s.Green Energy ResourcesvsUnion of India and others
M/s.Green Energy Resources filed a writ petition seeking the restoration of Patent No.343974, which had lapsed because renewal fees were not deposited by the Petitioner's authorized agent. The court considered arguments regarding agent negligence and the extension of limitation period due to the COVID-19 pandemic.
R.Vishnu PrasadvsThe Controller of Patents, The Patent Office
The appellant filed a Civil Miscellaneous Appeal challenging the order that deemed his patent application abandoned due to a four-day delay in filing the response to the First Examination Report (FER). The appellant argued that the delay was minor and attributable to clerical error, and that the Controller had sufficient power to condone such irregularities. The High Court found the reasons acceptable and condoned the delay.
Dunlop International Limited (and Dunlop Slazenger Group Ltd.)vsGlorious Investment Limited And Anr.
The Calcutta High Court set aside multiple appeals concerning the registration of the 'Dunlop' word mark. The core dispute revolved around the validity of assignments made by Dunlop India Ltd. during its liquidation period, which were used by Glorious Investment Limited to secure trademark rights in various classes. Given serious questions regarding fraud, natural justice violations, and the limited jurisdiction of the Registrar concerning assignment validity, the Court remanded all matters back for a fresh hearing after ensuring all parties are heard.
Medtronic Xomed, IncvsController General Of Patents, Designs and Trademarks And Anr
The Calcutta High Court addressed an opposition matter (OA/4/2018/PT/KOL) involving Medtronic Xomed, Inc. The court noted that no counsel appeared for the appellant on the hearing date. Consequently, the matter was adjourned to March 30, 2023, with specific directions issued to the respondent authorities to serve a copy of the application on the appellant and file an Affidavit of Service.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.